Literature DB >> 2403156

Infection and labor. VI. Prevalence, microbiology, and clinical significance of intraamniotic infection in twin gestations with preterm labor.

R Romero1, F Shamma, C Avila, C Jimenez, R Callahan, J Nores, M Mazor, C A Brekus, J C Hobbins.   

Abstract

The purpose of this study was to establish the prevalence, microbiology, and outcome of microbial invasion of the amniotic cavity in twin gestation presenting with preterm labor and intact membranes. Amniocenteses were performed on both sacs of 46 women with twin gestations, preterm labor, and intact membranes. Indigo carmine was injected to ensure sampling of both amniotic sacs. Amniotic fluid was cultured for aerobic and anaerobic bacteria, Mycoplasma hominis, and Ureaplasma urealyticum. A positive amniotic fluid culture of at least one sac was noted in 10.8% (5/46) of patients admitted in preterm labor and in 11.9% (5/42) of women delivered of preterm neonates. Of the five patients with microbial invasion of the amniotic cavity, three had microorganisms isolated from both sacs. The presenting sac was involved in all cases, supporting an ascending route for microbial invasion of the amniotic cavity in twin gestation. Polymicrobial infection was found in three of the eight amniotic sacs with positive cultures. In two cases different organisms were isolated from each sac. All patients with positive amniotic fluid cultures were delivered of preterm infants within 48 hours of amniocentesis. Patients with positive amniotic fluid cultures presented with preterm labor at an earlier gestational age and with more advanced cervical dilatation than did women with negative amniotic fluid cultures. Clinical evidence of chorioamnionitis subsequently developed in two of five women with positive amniotic fluid cultures. The interval between amniocentesis and delivery was shorter in women with positive amniotic fluid cultures than in women with negative amniotic fluid cultures (median: 3.5 vs 168 hours, p less than 0.0001). Infants born to women with microbial invasion of the amniotic cavity had a lower median birth weight and a higher incidence of respiratory distress syndrome than those born to women with negative amniotic fluid cultures (birth weight: 1085 vs 1975 gm, p = 0.024; respiratory distress syndrome: 37.5% vs 8.3%, p = 0.04).

Entities:  

Mesh:

Year:  1990        PMID: 2403156     DOI: 10.1016/0002-9378(90)91063-i

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  35 in total

1.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

Review 2.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 3.  The role of inflammation and infection in preterm birth.

Authors:  Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara Friel; Sonia Hassan
Journal:  Semin Reprod Med       Date:  2007-01       Impact factor: 1.303

4.  Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses.

Authors:  Daniel B DiGiulio; Maria Teresa Gervasi; Roberto Romero; Edi Vaisbuch; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

5.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

6.  Evidence that intra-amniotic infections are often the result of an ascending invasion - a molecular microbiological study.

Authors:  Roberto Romero; Nardhy Gomez-Lopez; Andrew D Winters; Eunjung Jung; Majid Shaman; Janine Bieda; Bogdan Panaitescu; Percy Pacora; Offer Erez; Jonathan M Greenberg; Madison M Ahmad; Chaur-Dong Hsu; Kevin R Theis
Journal:  J Perinat Med       Date:  2019-11-26       Impact factor: 1.901

7.  Quantitative microbiologic models for preterm delivery.

Authors:  Andrew B Onderdonk; Mei-Ling Lee; Ellice Lieberman; Mary L Delaney; Ruth E Tuomala
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

8.  Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Valeria Garcia-Flores; Yi Xu; Yaozhu Leng; Ali Alhousseini; Sonia S Hassan; Bogdan Panaitescu
Journal:  Am J Reprod Immunol       Date:  2017-07-13       Impact factor: 3.886

9.  Dysregulation of maternal serum adiponectin in preterm labor.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Chia-Ling Nhan-Chang; Cristiano Jodicke; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

10.  The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis.

Authors:  Nynke R van den Broek; Sarah A White; Mark Goodall; Chikondi Ntonya; Edith Kayira; George Kafulafula; James P Neilson
Journal:  PLoS Med       Date:  2009-12-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.